Trial Profile
Comparative Effects of Recombinant Human Brain Natriuretic Peptide and Dobutamine on Acute Decompensated Heart Failure Patients With Different Blood BNP Levels
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary) ; Dobutamine
- Indications Decompensated heart failure
- Focus Pharmacodynamics; Therapeutic Use
- 02 May 2013 New trial record